Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,025,104 papers from all fields of science
Search
Sign In
Create Free Account
Glomerulosclerosis (disorder)
Known as:
Glomerular sclerosis
, Glomerulosclerosis
A hardening of the kidney glomerulus caused by scarring of the blood vessels.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
CDISC SEND Non-Neoplastic Finding Type Terminology
Clinical Data Interchange Standards Consortium Terminology
Cockayne Syndrome, Type III
Dysautonomia, Familial
Expand
Narrower (1)
Focal glomerulosclerosis
Broader (2)
Kidney Diseases
arteriolonephrosclerosis
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Evaluations and utilizations of extended criteria donor kidneys
Zhi-gang Wang
,
Fei Xu
,
Lei Liu
,
Jinfeng Li
,
W. Shang
2019
Corpus ID: 219834461
Objective To explore the evaluations and recipient selection methods of extended criteria donor (ECD) kidney donation in the…
Expand
2016
2016
The magnitude of nephron number reduction mediates intrauterine growth-restriction-induced long term chronic renal disease in the rat. A comparative study in two experimental models
F. Boubred
,
L. Daniel
,
+4 authors
Umberto Simeoni
Journal of Translational Medicine
2016
Corpus ID: 255851772
Intrauterine growth restriction (IUGR) is a risk factor for hypertension (HT) and chronic renal disease (CRD). A reduction in the…
Expand
2012
2012
Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.
Natasha C. Moningka
,
T. Tsarova
,
J. Sasser
,
C. Baylis
Nephrology, Dialysis and Transplantation
2012
Corpus ID: 14670949
BACKGROUND Nitric oxide (NO) deficiency contributes to chronic kidney disease (CKD) progression and hypertension. The β-blocker…
Expand
2011
2011
Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1–7)
M. Igase
,
H. Yokoyama
,
C. Ferrario
Therapeutic Advances in Cardiovascular Disease
2011
Corpus ID: 12662110
Background: Controversy exists as to whether angiotensin (1–7) (Ang (1–7)) acts as a protective hormone against renal injury…
Expand
2008
2008
Papel do fósforo e do paratormônio na progressão da doença renal crônica
Andre Magalhaes
2008
Corpus ID: 73046017
2002
2002
The Role of the Renin-Angiotensin System in Cholesterol and Puromycin Mediated Renal Injury
S. Ghosh
,
D. Sica
,
+4 authors
T. Gehr
American Journal of the Medical Sciences
2002
Corpus ID: 22981488
BackgroundPuromycin aminonucleoside (PAN) nephropathy is a widely studied model of glomerular sclerosis (GS) in the rat, and…
Expand
1997
1997
C6: What does Insulin (INS) have to do with hyperlipidemia in Glomerular Sclerosis (GS)?
J. Toblli
,
O. Mazza
,
G. D. Rosa
,
P. Pagano
,
C. Nyberg
,
M. Angerosa
1997
Corpus ID: 72315531
1992
1992
[Effect of oral adsorbent (AST-120) in the rat model of chronic renal failure induced by adriamycin].
Y. Yoshida
,
M. Ise
Nihon Jinzo Gakkai shi
1992
Corpus ID: 23141440
The effect of AST-120 was examined in the rat model of CRF induced by adriamycin (ADM), which is known to induce focal glomerular…
Expand
1988
1988
A comparison of the effects of converting-enzyme inhibition and protein restriction in experimental nephrosis.
J. Beukers
,
P. Hoedemaeker
,
J. Weening
Laboratory investigation; a journal of technical…
1988
Corpus ID: 44462035
We compared the effects of protein restriction and converting-enzyme inhibition by captopril (CAP) on urinary protein excretion…
Expand
1980
1980
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN): A DOUBLE BLIND TRIAL OF ALTERNATE DAY PREDNISONE (ADP). International Study of Kidney Disease in Children
Pediatric Research
1980
Corpus ID: 42071471
A double blind trial of ADP is being conducted in children with MPGN and the nephrotic syndrome. Thirty-four children have been…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE